Market Indices
Latest News
 |
| ||
| ||
|
Price Targets
Ellie Jiang from Macquarie issued a price target of $67.50 for GDS on 2026-03-18 14:59:00.The adjusted price target was set to $67.50.At the time of the announcement, GDS...
March 18, 2026 GDS -4.20%
Yang Liu from Morgan Stanley issued a price target of $64.00 for GDS on 2026-03-17 19:21:00.The adjusted price target was set to $64.00.At the time of the announcement,
March 17, 2026 GDS -4.20%
Greg Renza from Truist Financial issued a price target of $8.00 for BCYC on 2026-03-17 15:51:00.The adjusted price target was set to $8.00.At the time of the announcement,
March 17, 2026 BCYC 3.06%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| AIXI Xiao-I Corporation | 0.12
24.85% | ||||||||||||||||||
| QNRX Quoin Pharmaceuticals, Lt | 6.96
14.85% | ||||||||||||||||||
| MSC Studio City International | 2.89
13.78% | ||||||||||||||||||
| AKO-A Embotelladora Andina S.A. | 24.80
11.81% | ||||||||||||||||||
| CNTB Connect Biopharma Holding | 2.99
9.93% | ||||||||||||||||||
| AMBO Ambow Education Holding L | 2.38
9.68% | ||||||||||||||||||
| CANG Cango Inc. | 0.47
9.07% | ||||||||||||||||||
| STKH Steakholder Foods Ltd. | 1.59
8.90% | ||||||||||||||||||
Annual/Quarterly Reports Summary
Summit Therapeutics Inc. (SMMT) Quarterly Report: What Does It Reveal About Their Sector Performance
May 1, 2025 SMMT 2.43%
In a landscape of rising revenues and increasing operational costs, the company navigates challenges with a focus on innovation and sustainability. Despite a dip in net income and profit declines...
February 5, 2025 TEVA -0.56%
In a year marked by resilience, the company celebrated record revenues of $25 billion, driven by strong ticket sales and operational efficiency. With a focus on North America, it reduced...
January 27, 2025 CUK -3.47%